Ep-CAM - A marker for the detection of disseminated tumor cells in patients suffering from SCCHN

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2237-2242

  Chaubal, Sarita ^a   Wollenberg, Barbara ^a   Kastenbauer, Ernst ^a   Zeidler, Reinhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bone marrow; Circulating tumor cells; Disseminated tumor cells; Ep CAM; Head and neck cancer; Marker for disseminated carcinoma cells; Metastases; RT PCR; SCCHN

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BONE MARROW; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANTIGENS, NEOPLASM; BONE MARROW; BONE MARROW CELLS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASM STAGING; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032774469     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mansi JL, Berger U, Easton D, McDonnell T, Redding WH, Gazet JC, McKinna A, Powles TJ and Coombes RC: Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093-1096, 1987.
2. Mansi JL, Berger U, McDonnell T, Pople A, Rayter Z, Gazet JC and Coombes RC: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7: 445-449, 1989.
3. Wollenberg B, Ollesch A, Maag K, Funke I & Wilmes E: Micrometastases in bone marrow of patients with cancers in the head and neck area. Laryngorhinootologie 73: 88-93, 1994.
4. Pantel K, Gath H & Heissler E: Staging of head and neck cancer [letter; comment]. N-Engl-J-Med 332: 1788; discussion 1789-1790, 1995.
5. Gath HJ, Heissler E, Hell B, Bier J, Riethmuller G and Pantel K: Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int J Oral Maxillofac Surg 24: 351-355, 1995.
6. Pelkey TJ, Frierson HF, Jr. and Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin-Chem 42: 1369-1381, 1996.
7. Nollau P, Jung R, Neumaier M and Wagener C: Tumour diagnosis by PCR-based detection of tumour cells. Scand J Clin Lab Invest Suppl 221: 116-121, 1995.
8. Ghossein RA and Rosai J: Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78: 10-16, 1996.
9. Kvalheim G: Detection of occult tumour cells in bone marrow and blood in breast cancer patients-methods and clinical significance. Acta Oncol 35 Suppl 8: 13-8, 1996.
10. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ and Warnaar SO: Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437-446, 1994.
11. Quak JJ, Van Dongen G, Brakkee JG, Hayashida DJ, Balm AJ, Snow GB and Meijer CJ: Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen. Hybridoma 9: 377-387, 1990.
12. Greenwald I: Structure/function studies of lin-12/Notch proteins. Curr Opin Genet Dev 4: 556-62, 1994.
13. Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ and Wamaar SO: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148: 865-875, 1996.
14. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, Thetter O and Riethmuller G: Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer-Res 53: 1027-1031, 1993.
15. Helfrich W, ten Poele R, Meersma GJ, Mulder NH, de Vries EG, de Leij L and Smit EF: A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood. Br J Cancer 76: 29-35, 1997.
16. Gusterson B: Are micrometastases clinically relevant? [editorial]. Br J Hosp Med 47: 247-248, 1992.
17. Zenner HP, Lehner W and Herrmann IF: Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol 225: 269-277, 1979.
18. Loos JA and Roos D: Ficoll-isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cells. Exp Cell Res 86: 333-341, 1974.
19. Bjork P, Jonsson U, Svedberg H, Larsson K, Lind P, Dillner J, Hedlund G, Dohlsten M and Kalland T: Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J Biol Chem 268: 24232-24241, 1993.
20. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H and Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-29, 1984.
21. van Dongen GA, Brakenhoff RM, ten Brink CT, van Gog FB, de Bree R, Quak JJ and Snow GB: Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. Anticancer Res 16: 2409-13, 1996.
22. Traweek ST, Liu J and Battifora H: Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142: 1111-1118, 1993.
23. Schrijvers AH, Gerretsen M, Fritz JM, van Walsum M, Quak JJ, Snow GB and van Dongen GA: Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp Cell Res 196: 264-269, 1991.
24. Schrijvers AH, Quak JJ, Uyterlinde AM, van Walsum M, Meijer CJ, Snow GB and van Dongen GA: MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck. Cancer-Res 53: 4383-4390, 1993.
25. Gottlinger HG, Funke I, Johnson JP, Gokel JM and Riethmuller G: The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38: 47-53, 1986.
26. Herlyn D, Somasundaram R, Zaloudik J, Jacob L, Harris D, Kieny MP, Sears H and Mastrangelo M: Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer. Cell Biophys 24: 143-153, 1994.
27. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R and et al: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343: 1177-1183, 1994.
28. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J and Riethmuller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8: 831-837, 1990.
29. Cote RJ, Rosen PP, Lesser ML, Old LJ and Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756, 1991.
30. Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmuller G: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689, 1992.
31. Funke I and Schraut W: Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-566, 1998.
32. Borkowski TA, Nelson AJ, Farr AG and Udey MC: Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur J Immunol 26: 110-114, 1996.
33. Slootweg PJ, Bolle CW, Koole R and Hordijk GJ: Cause of death in squamous cell carcinoma of the head and neck. An autopsy study on 31 patients. J Craniomaxillofac Surg 20: 225-227, 1992.